Company profile: ONI
1.1 - Company Overview
Company description
- Provider of super-resolution microscopy solutions, making this advanced technology accessible to new generations of researchers. Offers the Nanoimager, the world's first benchtop-sized super-resolution microscope, delivering a step change in usability and precision, together with next-generation consumable products.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ONI
Fujifilm Cellular Dynamics
HQ: United States
Website
- Description: Provider of human induced pluripotent stem cell (iPSC)-derived cells and media for disease and preclinical research, including iCell GABANeurons, DopaNeurons, GlutaNeurons, and Microglia for drug discovery, neurological research, and neurotoxicity testing. Offers iPSCs and custom iPSCs/iCell products (MyCell), plus CDMO services for contract development and cGMP manufacture of clinical-grade human cells in industrial quantities to precise specifications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fujifilm Cellular Dynamics company profile →
AMSBIO
HQ: United Kingdom
Website
- Description: Provider of life science technology products and services for R&D in medical, nutrition, cosmetics, and energy, including monoclonal, polyclonal, and secondary antibodies; GMP compliance support; FDA-aligned tissue arrays for immunohistochemistry; protein expression; transduction-ready lentivirus, adenovirus, and AAV; and peptide and antibody production services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AMSBIO company profile →
Meridian Bioscience
HQ: United States
Website
- Description: Provider of clinical diagnostic test kits, developing, manufacturing, marketing, and distributing assays for gastrointestinal, viral, respiratory, and parasitic infectious diseases, plus bulk antigens and antibodies. Portfolio includes BreathID Smart (H. pylori), Curian, Immunocard STAT!, Premier, Tru, and Merifluor offering rapid immunoassay, enzyme immunoassay, and fluorescent testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meridian Bioscience company profile →
Gyros Protein Technologies
HQ: United States
Website
- Description: Provider of peptide synthesizers, reagents, and bioanalysis platforms for universities, biotechnology and pharmaceutical companies, and peptide houses. Offers automated peptide synthesis systems for discovery to pre-clinical studies, Gyrolab systems for high-throughput immunoassays for impurity analysis and titer quantification, PurePep EasyClean kits for catch-and-release peptide purification, and IQ/OQ services for compliant installation and operation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gyros Protein Technologies company profile →
Akoya Biosciences
HQ: United States
Website
- Description: Provider of end-to-end spatial biology solutions for high-parameter tissue analysis from biomarker discovery through clinical and translational research, enabling more precise therapies in immuno-oncology and drug development; offerings include PhenoCycler for spatial phenotyping at unprecedented speeds and PhenoImager for comprehensive tissue analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akoya Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ONI
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ONI
2.2 - Growth funds investing in similar companies to ONI
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ONI
4.2 - Public trading comparable groups for ONI
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →